Course Provider
Learning Objectives
Upon completion of this activity, participants should be better able to describe the burden of anemia in patients with MDS, MF, and beta thalassemia, including impact on patient quality of life
Upon completion of this activity, participants should be better able to apply effective strategies for improving patient quality of life through engaging patients in shared decision-making
Upon completion of this activity, participants should be better able to assess challenges to prompt anemia evaluation and accurate differential diagnoses
Upon completion of this activity, participants should be better able to employ interprofessional strategies to optimize treatment, management, and outcomes for patients with symptomatic anemia
Upon completion of this activity, participants should be better able to examine the latest clinical data on the safety and efficacy of current and emerging therapies for anemia associated with lower-risk MDS, MF, and beta thalassemia